Active Ingredient History

NOW
  • Now
Ozanimod, sold under the brand name Zeposia, is an immunomodulatory medication for the treatment of relapsing multiple sclerosis (RMS) and ulcerative colitis. It acts as a sphingosine-1-phosphate (S1P) receptor agonist, sequestering lymphocytes to peripheral lymphoid organs and away from their sites of chronic inflammation.   Wikipedia

  • SMILES: CC(C)Oc1ccc(cc1C#N)c2onc(n2)c3cccc4[C@H](CCc34)NCCO
  • InChIKey: XRVDGNKRPOAQTN-FQEVSTJZSA-N
  • Mol. Mass: 404.47
  • ALogP: 3.63
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

Australia

$58.4917

United States

$176.3690 - $224.9603
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

ozanimod | rpc1063

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue